Health Care/Hospital

GLAC Biotech Wins Double Honors at the iSEE Global Innovation Awards Lactobacillus plantarum PL-02 Sets a New Benchmark for Functional Probiotics

TAIPEI, Nov. 11, 2025 /PRNewswire/ -- GLAC Biotech, a leading innovator in probiotics and postbiotics research, proudly announces another milestone on the global stage. Its flagship strain,Lactobacillus plantarum PL-02, has been honored withtwo major awards at the 7th iSEE Global Innovation Award...

2025-11-11 09:00 1100

Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics

* VxWave Ultrasound Imaging System demonstrated 94% scanning success rate and 100% data adequacy rate for vascular access creation strategies in CANSCAN trial * New insights into vascular anatomy made possible by standardized image acquisition and reporting * VxWave System has the potential t...

2025-11-11 05:32 1298

TraceLink Customers Demonstrate Readiness as DSCSA Dispenser Deadline Arrives

TraceLink Continues to Set the Standard for United States Drug Supply Chain Security (DSCSA) Leadership, Proven by Real-World Success, Industry Adoption, and Superior Service BOSTON, Nov. 10, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestr...

2025-11-10 23:00 1141

Brii Biosciences Presents Late-Breaking Data from Ongoing Phase 2 ENSURE Study at AASLD 2025, Reinforcing BRII-179's Potential as a Curative Treatment for Chronic Hepatitis B

* Cohort 4 follow-up confirms durable hepatitis B surface antigen (HBsAg) loss at 24 weeks post end of treatment (EOT) in BRII-179 anti-HBs responders treated with elebsiran plus pegylated interferon alfa (PEG-IFNα) * Data suggest the potential to shorten PEG-IFNα treatment duration for BRII-...

2025-11-10 21:30 2189

Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and sustained hematologic responses – - A novel mechanism targeting NEK7 and NLRP3 inflammasomes shows promise across multiple myeloid neoplasms – - Preclinical data reveal potential applications in hemolyti...

2025-11-10 21:15 1122

MediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at CIIE 2025 to Advance Drug-Insurance Integration New Model

HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd. ("M ediTrustHealth") signed a strategic cooperation agreement. The...

2025-11-10 14:18 1242

Rona Therapeutics Presents Phase 1 Data for RN0361, a Long-Acting APOC3-Targeting siRNA, at the American Heart Association 2025 Scientific Sessions

NEW ORLEANS, Nov. 10, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, presented highlights of Phase 1 clinical data for RN0361, a long-acting Apolipoprotein C3 (ApoC3) siRNA. RN0361 achieved potent, durable reductions in ApoC3 and triglycer...

2025-11-10 12:00 1992

Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress

CHENGDU, China, Nov. 10, 2025 /PRNewswire/ -- From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Kunming, Yunnan. This conference was jointly organized by the Chinese Anti-Cancer Association (CACA), the Tengchong Science Forum Organizing Committee ...

2025-11-10 10:01 1443

ICP DAS-BMP Attends MOU Signing Ceremony to Mark a New Milestone in Medical-Grade TPU Materials

HSINCHU, Nov. 10, 2025 /PRNewswire/ -- ICP DAS-BMP participated in the Strategic Memorandum of Understanding (MOU) signing ceremony organized by Towards Buddha Co., Ltd. onOctober 28, where it showcased its R&D achievements and diverse applications in medical-grade TPU materials. Moving forward, ...

2025-11-10 08:45 1231

Xinhua Silk Road: E. China's Weihai City establishes 18 TCM health tourism demonstration bases

BEIJING, Nov. 8, 2025 /PRNewswire/ -- Weihai, a prefecture-level city in east China's Shandong Province, has seen the establishment of 18 traditional Chinese medicine (TCM) health tourism demonstration bases, including the Weihai Tianmu Hot Spring Resort, as the city has emphasized the deep integ...

2025-11-08 20:48 1854

inne Debuts at CIIE with Global Launch of Two New Products

SHANGHAI, Nov. 8, 2025 /PRNewswire/ -- The 8th China International Import Expo (CIIE) commenced onNov. 5 in Shanghai, China. The world's leading children's nutrition brand inne® was invited to participate, showcasing a range of its innovative achievements on this international stage and seizing t...

2025-11-08 11:23 2040

2025 Aurora Prize for Awakening Humanity Awarded to Dr. Jamal Eltaeb

Head of Al Nao Hospital in Sudan recognized for sustaining critical medical care amid civil war and saving hundreds of lives NEW YORK, Nov. 8, 2025 /PRNewswire/ -- The Aurora Humanitarian Initiative announced Thursday evening thatDr. Jamal Eltaeb

2025-11-08 00:03 741

Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine

* Findings provide scientific insights into the contribution of small interfering RNA (siRNA) and therapeutic vaccination towards the HBV functional cure strategy DURHAM, N.C. and BEIJING, Nov. 7, 2025 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio," or the "Com...

2025-11-07 21:30 1747

EBR Systems Achieves First Enrollments in the WiSE-UP Study for Heart Failure Patients

The WiSE-UP post-approval study is gathering real-world evidence from commercially treated patients using the WiSE® left ventricular endocardial pacing (LVEP) system. Key Highlights: * The first two patients have now been enrolled in the WiSE-UP post-approval study by DrDevi Nair from St Bern...

2025-11-07 21:00 1037

Pigeon Showcases Parenting Innovations Under "The Nest" Theme at CIIE 2025

SHANGHAI, Nov. 7, 2025 /PRNewswire/ -- During the 8th China International Import Expo (CIIE) at the National Exhibition and Convention Center, Pigeon unveiled its latest advances in feeding and baby care science under the theme "The Nest". ...

2025-11-07 20:20 1515

Cranial Technologies Debuts NMPA-Cleared Infant Head Reshaping Treatment in China at CIIE

SHANGHAI, Nov. 7, 2025 /PRNewswire/ -- Cranial Technologies, a leading US medical device company specializing in the treatment of infant head shape conditions, officially introduced its flagship DOC Band® treatment in the Chinese market at the China International Import Expo (CIIE), taking place ...

2025-11-07 15:58 1075

Fosun International Honored with Gold Award and Best Sustainability Team at The Asset Corporate Sustainability Leadership Awards 2025

HONG KONG, Nov. 7, 2025 /PRNewswire/ -- On the evening of 6 November 2025, The Asset, a renowned Asian financial magazine, hosted "The Asset Corporate Sustainability Leadership Awards 2025" ceremony inSingapore. Fosun International Limited ("Fosun International" or the "Company") (HKEX stock cod...

2025-11-07 09:00 3096

Australian Sleep Tech Company Launches a Smart Ring to Transform Sleep & Health - retimer Ring

ADELAIDE, Australia, Nov. 7, 2025 /PRNewswire/ -- Re-Time Pty Ltd (RTPL) today announced the launch of the retimer Ring, the first smart ring solution developed by an Australian company to help people improve sleep and overall wellbeing. Building on a legacy of more than 25 years of research at F...

2025-11-07 07:00 1358

Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally

SYDNEY, Nov. 7, 2025 /PRNewswire/ -- Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close of itsA$25 million Series B financing round. The round was led by Aviron Investment Management with continued participation from Oncology Ventures.

2025-11-07 06:00 1246

Jungbunzlauer closes acquisition of Illinois facility to launch U.S. manufacturing operations

– Strategic investment enhances service to North American customers and supports rising market demand for high-quality ingredients – BASEL, Switzerland, Nov. 6, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality ingredients from natural sources, today announced the successful cl...

2025-11-06 22:00 1100
1 ... 13141516171819 ... 551

Week's Top Stories